What are the possible causes of clonus in a patient on paliperidone and risperidone who experienced a seizure after excessive water intake causing hyponatremia, accompanied by fever, leukocytosis, and elevated creatine kinase levels?

Differential Diagnosis for Clonus in Patient on Paliperidone and Risperidone

This patient most likely has Neuroleptic Malignant Syndrome (NMS), though serotonin syndrome and hyponatremia-induced seizure complications must also be considered in the differential.

Primary Diagnosis: Neuroleptic Malignant Syndrome (NMS)

The constellation of fever, elevated CK, leukocytosis, and clonus in a patient on dual dopamine antagonists (paliperidone and risperidone) strongly suggests NMS 1. NMS presents with the classic tetrad: mental status changes, fever, muscle rigidity/hypertonicity, and autonomic dysfunction 1.

Key Supporting Features:

• Elevated CK levels: Indicative of muscle breakdown from rigidity and increased contractility due to calcium release from sarcoplasmic reticulum 1
• Fever: Results from D2 receptor blockade in hypothalamus causing increased set point and loss of heat-dissipating mechanisms 1
• Leukocytosis: Common laboratory finding in NMS 1
• Clonus/rigidity: Caused by D2 receptor antagonism in nigrostriatal pathways and spinal cord 1
• Dual antipsychotic therapy: Coadministration of psychotropic agents is an especially high risk factor for NMS 1

Important caveat: The patient is on both paliperidone and risperidone simultaneously—paliperidone is the active metabolite of risperidone, meaning this represents excessive dopaminergic blockade 2, 3. This combination significantly increases NMS risk.

Atypical Presentation Considerations:

NMS can present without classic "lead pipe rigidity" 4. The presence of clonus rather than pure rigidity does not exclude NMS, as motor abnormalities may include rigidity, akinesia, intermittent tremors, and involuntary movements 1. Recent case reports document atypical NMS presentations with altered mental status and elevated CK as primary features 5, 4.

Secondary Consideration: Serotonin Syndrome

While less likely given the medication profile, serotonin syndrome must be differentiated from NMS 1.

Distinguishing Features:

• Clonus and hyperreflexia are highly diagnostic for serotonin syndrome 1
• Serotonin syndrome typically develops within 24-48 hours of medication changes 6
• Clinical triad: mental status changes, autonomic hyperactivity, neuromuscular abnormalities (tremor, clonus, hyperreflexia, muscle rigidity) 6

However, paliperidone and risperidone are primarily dopamine antagonists, not serotonergic agents 7. Unless the patient is on concurrent serotonergic medications not mentioned, serotonin syndrome is less probable.

Tertiary Consideration: Hyponatremia-Related Complications

The seizure following excessive water drinking with resultant hyponatremia adds complexity 8.

Hyponatremia Effects:

• Seizures lower the seizure threshold further 7
• Antipsychotics independently lower seizure threshold in dose-dependent manner 1
• Post-ictal state can cause transient neurological findings including clonus
• Severe hyponatremia can cause confusion, seizures, and altered mental status 8

Critical point: Psychogenic polydipsia is common in patients with schizophrenia on antipsychotics and can lead to life-threatening hyponatremia 8. The excessive water drinking may have been the precipitant for the seizure, but does not fully explain the fever, elevated CK, and leukocytosis.

Additional Differential Considerations

Post-Ictal Rhabdomyolysis:

• Seizures themselves can cause elevated CK and muscle breakdown 9
• However, this typically resolves within days and doesn't explain persistent fever or rigidity

Infection/Sepsis:

• Fever and leukocytosis could suggest infection 4
• However, the temporal relationship to antipsychotic use, elevated CK, and clonus make this less likely as primary diagnosis
• Must still rule out concurrent infection, as dehydration from excessive water loss and aspiration risk are NMS complications 1

Extrapyramidal Symptoms (EPS):

• Paliperidone and risperidone can cause acute extrapyramidal syndromes 1, 2
• Recent case reports document severe EPS with paliperidone, especially when combined with other medications 2
• However, isolated EPS doesn't explain fever, elevated CK, and leukocytosis

Diagnostic Algorithm

Immediate priorities:

1. Discontinue both paliperidone and risperidone immediately 1, 3
2. Check core temperature, vital signs for autonomic instability (blood pressure fluctuations, tachycardia, diaphoresis) 1
3. Assess muscle tone carefully: Look for rigidity (may be subtle), tremor, akinesia 1
4. Serial CK levels: Trend to assess for ongoing muscle breakdown 1, 10, 11
5. Comprehensive metabolic panel: Assess sodium correction rate (too rapid correction risks osmotic demyelination), renal function (rhabdomyolysis can cause acute kidney injury) 1
6. Rule out infection: Blood cultures, urinalysis, chest X-ray if aspiration suspected 1
7. Monitor for complications: Renal failure, metabolic acidosis, disseminated intravascular coagulation 1

Management Priorities

For presumed NMS:

• Supportive care is primary treatment 1
• IV fluids for dehydration and rhabdomyolysis 1
• External cooling for hyperthermia (cooling blankets) 1
• Benzodiazepines for agitation (first-line agent) 1
• Monitor for renal failure requiring hemodialysis 1

For hyponatremia:

• Cautious sodium correction to prevent osmotic demyelination syndrome 8
• Fluid restriction once seizure risk addressed 8
• Behavioral modification for psychogenic polydipsia 8

Critical warning: Do not use physical restraints if agitation develops—they exacerbate isometric contractions, worsening hyperthermia and lactic acidosis, increasing mortality 1.

Common Pitfalls

1. Attributing all findings to post-ictal state: The combination of fever, elevated CK, leukocytosis, and clonus in context of dual antipsychotic therapy is NMS until proven otherwise 10, 11, 5

2. Overlooking medication duplication: Paliperidone IS risperidone's active metabolite—using both simultaneously creates excessive dopamine blockade 2, 3

3. Premature antipsychotic rechallenge: NMS mortality has decreased to <10-15%, but reintroduction of causative agent can trigger recurrence 1, 10. Wait for complete resolution and consider alternative agent when restarting 3

4. Missing psychogenic polydipsia: This patient's excessive water drinking requires behavioral intervention and monitoring to prevent recurrent hyponatremia 8

5. Assuming normal CK excludes NMS: While elevated CK is typical, normal CK levels in NMS have been reported 11. Clinical presentation takes precedence.